MOREADITH RANDALL (Chief Scientific Officer) sold 6.50K shares of SERINA THERAPEUTICS, INC. on the open market
Open‑market sale worth $19.7K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/3/2026ACC: 0001301120-26-000012
Officer· Chief Scientific Officer
Since Feb 2026
-6.50K
Net shares
Net seller
$19.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.50K acquired · 13K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.50K
Price / share
$0.06
Trade value
$390.00
% of position
New position
2/2/2026
0.00→6.50K
Common Stock
Direct
Shares
−6.50K
Price / share
$3.03
Trade value
$19.68K
% of position
New position
2/2/2026
6.50K→0.00
Total
Net shares
+0.00
Net value
-$19.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | M · Option Exercise | +6.50K | $0.06 | $390.00 | New position | 0.00 | 6.50K |
| Common Stock Direct | 2/2/2026 | S · Sale | −6.50K | $3.03 | $19.68K | New position | 6.50K | 0.00 |
| Total | +0.00 | -$19.29K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
6.50K shares
Shares
−6.50K
Strike price
0.06
Held after
313.19K
Exercisable
—
2/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock6.50K shares | 2/2/2026 | M · Option Exercise | −6.50K | 0.06 | — | 313.19K |